Literature DB >> 4039601

Retinal function of the diabetic retina after argon laser photocoagulation assessed electroretinographically.

I Perlman, M Gdal-On, B Miller, S Zonis.   

Abstract

Electroretinographic (ERG) responses were measured in diabetic patients before, during, and after panretinal photocoagulation treatment with argon laser. The laser applications reduced considerably the amplitudes of the a and b waves of the ERG. Moreover, the relationship between the amplitude of the b wave and that of the a wave was severely affected, resulting in ERG responses of abnormal pattern. The b waves were smaller than expected from the a waves. These findings indicated that the photocoagulation treatment not only destroyed the retinal areas directly illuminated by the laser beam, but also affected the functional integrity of adjacent areas. These additional effects resulted in subnormal signal transmission from the photoreceptors to the proximal retina.

Entities:  

Mesh:

Year:  1985        PMID: 4039601      PMCID: PMC1040575          DOI: 10.1136/bjo.69.4.240

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Visual fields and electroretinography following extensive photocoagulation.

Authors:  R N Frank
Journal:  Arch Ophthalmol       Date:  1975-08

2.  The influence of photocoagulation of the retina on the electroretinogram.

Authors:  R P Schuurmans; W A Lege; G H Lith; J A Oosterhuis
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

3.  The electroretinogram after peripheral retinal ablation in diabetic retinopathy.

Authors:  T E Ogden; F Callahan; F T Riekhof
Journal:  Am J Ophthalmol       Date:  1976-04       Impact factor: 5.258

4.  Electrophysiological studies before and after argon-laser photocoagulation in diabetic retinopathy.

Authors:  J François; A De Rouck; E Cambie; A Castanheira-Dinis
Journal:  Ophthalmologica       Date:  1977       Impact factor: 3.250

5.  Photocoagulation in diabetic retinopathy.

Authors:  A E Krill; D B Archer; F W Newell; M I Chishti
Journal:  Am J Ophthalmol       Date:  1971-08       Impact factor: 5.258

6.  Relationship between the amplitudes of the b wave and the a wave as a useful index for evaluating the electroretinogram.

Authors:  I Perlman
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

7.  Comparative electroretinograms in argon laser and xenon arc panretinal photocoagulation.

Authors:  J C Liang; G A Fishman; F U Huamonte; R J Anderson
Journal:  Br J Ophthalmol       Date:  1983-08       Impact factor: 4.638

  7 in total
  14 in total

1.  Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Authors:  André Messias; José Afonso Ramos Filho; Katharina Messias; Felipe P P Almeida; Rogério A Costa; Ingrid U Scott; Florian Gekeler; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

2.  Relationships between the electroretinogram a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis.

Authors:  H Asi; I Perlman
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers.

Authors:  C Capoferri; M Bagini; A Chizzoli; A Pece; R Brancato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation.

Authors:  Haiyun Ye; Minzhong Yu; Lin Lu; Chenjin Jin; Guangwei Luo
Journal:  Lasers Med Sci       Date:  2018-03-15       Impact factor: 3.161

5.  The electroretinogram in minimal diabetic retinopathy.

Authors:  T C Jenkins; J P Cartwright
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

6.  Visual function in hypermetropia. An electroretinographic and psychophysical study.

Authors:  R Kennet; E Meyer; I Perlman
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

7.  Macular function assessed with mfERG before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.

Authors:  Monica Lövestam-Adrian; Sten Andréasson; Vesna Ponjavic
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

8.  Function of the diabetic retina after panretinal argon laser coagulation.

Authors:  V Seiberth; E Alexandridis; W Feng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

9.  Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test.

Authors:  G B Arden; A M Hamilton; J Wilson-Holt; S Ryan; J S Yudkin; A Kurtz
Journal:  Br J Ophthalmol       Date:  1986-05       Impact factor: 4.638

10.  Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy.

Authors:  Taiichi Hikichi; Naohiro Tateda; Toshiaki Miura
Journal:  Clin Ophthalmol       Date:  2011-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.